Effect of the 5-lipoxygenase inhibitor ZD2138 on allergen-induced early and late asthmatic responses.

Documenti analoghi

• Effect of the 5-lipoxygenase inhibitor ZD2138 on aspirin-induced asthma.
  di: Nasser, S. M., et al.
  Pubblicazione: (1994)
• Pre-clinical pharmacology of ICI D2138, a potent orally-active non-redox inhibitor of 5-lipoxygenase.
  di: McMillan, R. M., et al.
  Pubblicazione: (1992)
• Attenuation of early and late phase allergen-induced bronchoconstriction in asthmatic subjects by a 5-lipoxygenase activating protein antagonist, BAYx 1005
  di: Hamilton, A. L., et al.
  Pubblicazione: (1997)
• Effect of cyclosporin A on the allergen-induced late asthmatic reaction
  di: Sihra, B. S., et al.
  Pubblicazione: (1997)
• Effect of a 5-lipoxygenase inhibitor on leukotriene generation and airway responses after allergen challenge in asthmatic patients.
  di: Hui, K P, et al.
  Pubblicazione: (1991)